Grainger S. Lanneau

1.2k total citations
24 papers, 854 citations indexed

About

Grainger S. Lanneau is a scholar working on Obstetrics and Gynecology, Epidemiology and Oncology. According to data from OpenAlex, Grainger S. Lanneau has authored 24 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Obstetrics and Gynecology, 11 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Grainger S. Lanneau's work include Cervical Cancer and HPV Research (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Ovarian cancer diagnosis and treatment (5 papers). Grainger S. Lanneau is often cited by papers focused on Cervical Cancer and HPV Research (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Ovarian cancer diagnosis and treatment (5 papers). Grainger S. Lanneau collaborates with scholars based in United States, Australia and Canada. Grainger S. Lanneau's co-authors include Everett F. Magann, John C. Morrison, Joan L. Walker, Sharon Evans, Michael A. Gold, Kathleen N. Moore, Lisa M. Landrum, Rosemary E. Zuna, M. Hutchinson and Baoyun Xia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and American Journal of Obstetrics and Gynecology.

In The Last Decade

Grainger S. Lanneau

24 papers receiving 822 citations

Peers

Grainger S. Lanneau

PPCH

SURGE

EPIDE

Young Nam Kim South Korea

Khalid Sait Saudi Arabia

Iztok Takač Slovenia

J Brock Germany

J Tošner Czechia

Ido Laskov Israel

Kyeong A So South Korea

Ralph J. Anderson United States

Giuseppe Scaletta Italy

Xufeng Wu China

Young Nam Kim South Korea

Grainger S. Lanneau

369 ×1.1

146 ×0.6

222 ×0.9

PPCH

87 ×0.4

SURGE

162 ×1.0

EPIDE

Citations per year, relative to Grainger S. Lanneau Grainger S. Lanneau (= 1×) peers Young Nam Kim

Countries citing papers authored by Grainger S. Lanneau

Since Specialization

Citations

This map shows the geographic impact of Grainger S. Lanneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grainger S. Lanneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grainger S. Lanneau more than expected).

Fields of papers citing papers by Grainger S. Lanneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grainger S. Lanneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grainger S. Lanneau. The network helps show where Grainger S. Lanneau may publish in the future.

Co-authorship network of co-authors of Grainger S. Lanneau

This figure shows the co-authorship network connecting the top 25 collaborators of Grainger S. Lanneau. A scholar is included among the top collaborators of Grainger S. Lanneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grainger S. Lanneau. Grainger S. Lanneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moore, Kathleen N., Ana Oaknin, Isabelle Ray‐Coquard, et al.. (2024). GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers. Gynecologic Oncology. 190. S281–S282. 1 indexed citations

Moore, Kathleen N., Ana Oaknin, Isabelle Ray‐Coquard, et al.. (2023). #24 A phase 2 study (GOG-3084) OF ADP-A2M4CD8 TCR T-cell therapy, alone or in combination with nivolumab, in patients with recurrent ovarian cancers. A407.2–A408. 1 indexed citations

Lanneau, Grainger S., et al.. (2014). Concurrent Anal Human Papillomavirus and Abnormal Anal Cytology in Women With Known Cervical Dysplasia. Obstetrics and Gynecology. 124(2). 242–248. 20 indexed citations

Landrum, Lisa M., James Java, Cara Mathews, et al.. (2013). Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study. Gynecologic Oncology. 130(1). 12–18. 111 indexed citations

Mathews, Cara, Julie A. Stoner, Nicolas Wentzensen, et al.. (2012). Tubal ligation frequency in Oklahoma women with cervical cancer. Gynecologic Oncology. 127(2). 278–282. 5 indexed citations

Lanneau, Grainger S., Peter A. Argenta, Robert H. Riffenburgh, et al.. (2009). Vulvar cancer in young women: demographic features and outcome evaluation. American Journal of Obstetrics and Gynecology. 200(6). 645.e1–645.e5. 33 indexed citations

Moore, Kathleen N., et al.. (2009). Cervical Dysplasia Among Women Over 35 Years of Age. Obstetrical & Gynecological Survey. 64(3). 160–161. 1 indexed citations

Ju, Tongzhong, Grainger S. Lanneau, Tripti Gautam, et al.. (2008). Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc. Cancer Research. 68(6). 1636–1646. 232 indexed citations

Landrum, Lisa M., Kathleen N. Moore, Tashanna Myers, et al.. (2008). Stage IVB endometrial cancer: Does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Gynecologic Oncology. 112(2). 337–341. 40 indexed citations

10.

Moore, Kathleen N., et al.. (2008). Cervical dysplasia among women over 35 years of age. American Journal of Obstetrics and Gynecology. 199(5). 471.e1–471.e5. 13 indexed citations

11.

Moore, Kathleen N., et al.. (2007). Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes. American Journal of Obstetrics and Gynecology. 197(2). 141.e1–141.e6. 77 indexed citations

12.

Moore, Kathleen N., et al.. (2007). Pathologic findings and outcomes for octogenarians presenting with uterine malignancy. Gynecologic Oncology. 106(3). 572–578. 6 indexed citations

13.

Lanneau, Grainger S., Valerie Skaggs, Kathleen N. Moore, et al.. (2007). A LEEP Cervical Conization Is Rarely Indicated for a Two-Step Discrepancy. Journal of Lower Genital Tract Disease. 11(3). 134–137. 5 indexed citations

14.

Landrum, Lisa M., Grainger S. Lanneau, Valerie Skaggs, et al.. (2007). Gynecologic Oncology Group risk groups for vulvar carcinoma: Improvement in survival in the modern era. Gynecologic Oncology. 106(3). 521–525. 18 indexed citations

15.

Magann, Everett F., Dorota A. Doherty, Kendrick B. Turner, et al.. (2006). Second trimester placental location as a predictor of an adverse pregnancy outcome. Journal of Perinatology. 27(1). 9–14. 54 indexed citations

16.

Magann, Everett F., et al.. (2005). Postpartum Hemorrhage After Cesarean Delivery: An Analysis of Risk Factors. Southern Medical Journal. 98(7). 681–685. 116 indexed citations

17.

Magann, Everett F., et al.. (2005). The Length of the Third Stage of Labor and the Risk of Postpartum Hemorrhage. Obstetrics and Gynecology. 105(2). 290–293. 86 indexed citations

18.

Magann, Everett F. & Grainger S. Lanneau. (2005). Third Stage of Labor. Obstetrics and Gynecology Clinics of North America. 32(2). 323–332. 10 indexed citations

19.

Lanneau, Grainger S., et al.. (2005). Well-differentiated papillary mesothelioma of the uterine serosa identified at cesarean section: a case report.. PubMed. 50(11). 860–2. 3 indexed citations

20.

Magann, Everett F., Dorota A. Doherty, Suneet P. Chauhan, Grainger S. Lanneau, & John C. Morrison. (2004). Dye-Determined Amniotic Fluid Volume and Intrapartum/Neonatal Outcome. Journal of Perinatology. 24(7). 423–428. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact